‘Molecular glue’ harnesses the power of the immune system to treat neuroblastoma
Gene expression governs whether neuroblastoma tumor cells exist in either the adrenergic (differentiated and sensitive to treatment) or mesenchymal (less differentiated and therapy-resistant) cell state.